Monday, 25 November 2019

FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose

Adamis Pharmaceuticals Corp said on Monday its opioid overdose treatment was rejected by the U.S. Food and Drug Administration.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)